A pregnant client at 28 weeks gestation is admitted with placental abruption and develops disseminated intravascular coagulation (DIC). Which laboratory finding would be most indicative of DIC in this client?

DIC involves consumption of clotting factors and fibrinolysis, leading to decreased fibrinogen and elevated FDPs. Other options do not reflect the characteristic lab abnormalities of DIC.

Understanding the Pathophysiology of DIC in Placental Abruption

When a placental abruption occurs, the protective barrier between maternal circulation and the placenta is disrupted. This exposes maternal blood to large amounts of tissue factor (thromboplastin) from the damaged decidua and placental tissue. This event triggers a massive, systemic activation of the coagulation cascade, the hallmark of disseminated intravascular coagulation (DIC). The body's clotting system goes into overdrive, forming widespread microthrombi in the vasculature. This process rapidly consumes clotting factors and platelets faster than the liver and bone marrow can produce them, paradoxically leading to a severe bleeding tendency ^[3].

Interpreting the Laboratory Hallmarks of DIC

The diagnosis of DIC is not based on a single test but on a pattern of laboratory abnormalities reflecting this consumption coagulopathy. The most indicative finding in this scenario is a combination of decreased fibrinogen and elevated fibrin degradation products (FDPs).

Fibrinogen is a soluble clotting factor (Factor I) that is converted into insoluble fibrin to form a stable clot. In DIC, the widespread formation of microthrombi leads to a massive consumption of fibrinogen, causing its plasma level to fall significantly. A low fibrinogen level is a critical marker of consumption and is directly linked to bleeding risk in obstetric DIC ^[2].

Simultaneously, the body attempts to dissolve these widespread clots by activating the fibrinolytic system. Plasmin breaks down the fibrin clots into fragments known as fibrin degradation products (FDPs), which include D-dimer. The laboratory finding of elevated FDPs or D-dimer provides direct evidence of both active clot formation and subsequent fibrinolysis [2, 3]. The combination of a depleted clotting factor (low fibrinogen) and the byproducts of clot breakdown (high FDPs) is a classic and specific laboratory picture for acute, consumption-driven DIC.

Why the Other Options Are Incorrect

- Option 1: Elevated fibrinogen levels and decreased platelet count. Fibrinogen is an acute-phase reactant and can be elevated in normal pregnancy. However, in acute DIC, the defining feature is the consumption and subsequent depletion of fibrinogen, not an elevation. While a decreased platelet count is consistent with DIC, an elevated fibrinogen level contradicts the diagnosis of an active consumptive process ^[3].
- Option 2: Normal prothrombin time (PT) and elevated D-dimer. The prothrombin time (PT) measures the extrinsic and common coagulation pathways. In DIC, the consumption of multiple coagulation factors (like Factors V, VII, X, and prothrombin) invariably leads to a prolonged PT. A normal PT would be an unusual finding in a significant consumptive coagulopathy and does not align with the expected laboratory profile ^[2].
- Option 4: Increased platelet count and prolonged partial thromboplastin time (PTT). DIC is characterized by thrombocytopenia (a decreased platelet count) due to their consumption in widespread microthrombi. An increased platelet count is not a feature of DIC. While a prolonged partial thromboplastin time (PTT) is expected as intrinsic pathway factors are consumed, the incorrect platelet count makes this option invalid ^[3].